Literature DB >> 18396404

Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.

Anna Albrecht1, Jacek F Koszuk, Jakub Modranka, Marek Rózalski, Urszula Krajewska, Anna Janecka, Kazimierz Studzian, Tomasz Janecki.   

Abstract

A series of 5-aryl-3-alkylidenedihydrofuran-2(3H)-ones 6a-g'' and 11a,b as well as 5-aryl-3-methylidenepyrrolidin-2-ones 10a-c and 12 were synthesized starting from 4-aryl-2-diethoxyphosphoryl-4-oxobutanoates 3a-g. Reaction sequence includes reduction or reductive amination of the carbonyl group, lactonization or lactamization step and finally the Horner-Wadsworth-Emmons olefination of aldehydes using thus obtained 5-aryl-3-diethoxyphosphoryl-3,4-dihydrofuran-2(5H)-ones 5a-g'' or 5-aryl-3-diethoxyphosphorylpyrrolidin-2-ones 9a-c. Furanones 6 and 11, as well as pyrrolidinones 10 and 12, were evaluated in vitro against mouse leukemia cell line L-1210 and two human leukemia cell lines HL-60 and NALM-6. Several of the obtained furanones proved to be very potent against all three cell lines with IC(50) values lower than 6 microM. Structure-activity relationships of these compounds, as well as 5-alkyl or 5-arylmethyl-3-methylidenedihydrofuran-2(3H)-ones 13a-e, previously obtained in our laboratory, are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396404     DOI: 10.1016/j.bmc.2008.03.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Quinoline based furanones and their nitrogen analogues: Docking, synthesis and biological evaluation.

Authors:  Sukhbir Lal Khokra; Pawan Kaushik; M M Alam; M S Zaman; Aftab Ahmad; Shah Alam Khan; Asif Husain
Journal:  Saudi Pharm J       Date:  2015-06-11       Impact factor: 4.330

Review 2.  The Role of Bcl-xL Protein Research in Veterinary Oncology.

Authors:  Aleksandra Pawlak; Marta Henklewska
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.